Healing

Healing is a French biotechnology company dedicated to developing innovative therapies for the treatment of organ fibrosis. The company focuses on identifying and targeting key pathways involved in the fibrotic process, particularly those related to the Transforming Growth Factor Beta (TGF-β) signaling cascade. By leveraging its proprietary discovery platform, Healing aims to create disease-modifying treatments for high-need conditions such as systemic sclerosis and idiopathic pulmonary fibrosis. Their approach combines deep biological insights with advanced drug discovery techniques to address the underlying causes of tissue scarring and organ dysfunction.